CD274 and hematologic disorder: The PD-1/PD-L1 pathway plays a critical role in the prevention of abnormal autoimmune responses, and blockade of the PD-1/PD-L1 pathway was demonstrated to be an effective treatment for hematologic malignancies by clinical enhancement of the immune response (32, 33).